Pipecolic Acid 4-Hydroxylase for Specific 4-Position Hydroxylation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing optically active 4-hydroxy amino acids are inefficient due to high costs, complex processes, and limited applicability, with existing enzymes not effectively hydroxylating pipecolic acid at the 4-position.
Innovation Solution
Identification and utilization of the pipecolic acid 4-hydroxylase protein from Fusarium oxysporum Fo5176, which, when expressed in recombinant cells, enables the production of optically active 4-hydroxy amino acids with high optical purity using 2-oxoglutaric acid and iron(II) ions as cofactors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing proline hydroxylases are used to hydroxylate pipecolic acid, then 3-position or 5-position hydroxylation occurs, but 4-position hydroxylation cannot be achieved
Solution Approach 1:
The patent introduces a novel pipecolic acid 4-hydroxylase enzyme as an intermediary catalyst that specifically mediates 4-position hydroxylation of pipecolic acid, which existing proline hydroxylases cannot achieve. This specialized enzyme acts as a mediator between the substrate (pipecolic acid) and the desired product (4-hydroxypipecolic acid), resolving the position specificity issue.
Solution Approach 2:
The patent changes the enzymatic parameters by introducing a novel enzyme with different catalytic properties compared to existing proline hydroxylases. The new enzyme has specific amino acid sequence variations (SEQ ID NOs: 2, 4, 6, 8, 10, 12) that alter its active site geometry and cofactor binding, enabling it to selectively hydroxylate the 4-position of pipecolic acid rather than the 3 or 5 positions.
2Manufacturing precision
If conventional synthesis methods are used to produce optically active 4-hydroxy amino acids, then production can be achieved, but the process becomes expensive and complex
Solution Approach 1:
The patent replaces complex chemical synthesis mechanisms with a biological enzymatic mechanism. Instead of using multiple chemical reagents and complex reaction conditions to achieve optical purity, the invention uses a biocatalyst (pipecolic acid 4-hydroxylase) that naturally provides stereoselectivity and simplifies the production process while maintaining high optical purity.
Solution Approach 2:
The enzyme system performs self-service by providing inherent stereoselectivity and catalytic activity without requiring additional complex purification or resolution steps. The pipecolic acid 4-hydroxylase naturally produces optically active 4-hydroxy amino acids with high enantiomeric excess, eliminating the need for expensive chiral auxiliaries or complex separation processes.
3Productivity
If existing synthesis methods are used for 4-hydroxy amino acids, then production is possible, but efficiency is reduced due to high costs and limited applicability
Solution Approach 1:
The patent creates a universal enzymatic platform that can produce various optically active 4-hydroxy amino acids (including 4-hydroxy-L-proline, 4-hydroxy-D-proline, and 4-hydroxypipecolic acid enantiomers) using the same pipecolic acid 4-hydroxylase catalyst. This multi-functional approach increases productivity by eliminating the need for different synthesis routes for different products and reduces manufacturing costs through enzyme reuse and simplified processes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the efficient and cost-effective production of optically active 4-hydroxy amino acids, such as (4S)-hydroxy-L-pipecolic acid, with high optical purity, making them suitable intermediates for pharmaceuticals.
Implementation Method 1
a pipecolic acid 4-hydroxylase protein having activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions, to produce trans-4-hydroxy-L-pipecolic acid
Implementation Method 2
produce optically active 4-hydroxy amino acids with high optical purity
Data Source
AI summary
The present invention provides a pipecolic acid 4-hydroxylase protein exemplified by the following (A), (B), and (C), having activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions to produce trans-4-hydroxy-L-pipecolic acid, and a method for producing 4-hydroxy amino acid, which method comprises reacting the pipecolic acid 4-hydroxylase protein, cells containing the protein, a treated product of the cells, and/or a culture liquid obtained by culturing the cells, with α-amino acid to produce 4-hydroxy amino acid:(A) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18;(B) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18 except that one or several amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity; and(C) a polypeptide having an amino acid sequence that is not less than 80% identical to the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18, and having pipecolic acid 4-hydroxylase activity.